LEVEL 4 C02CA04

Δραστικές

DOXAZOSIN

Φάρμακα

  • DRUGBANK - Doxazosin
  • indication:

    For treatment and management of mild to moderate hypertension and urinary obstruction symptoms caused by BPH.

  • pharmacology:

  • mechanism:

    Doxazosin acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation.

  • toxicity:

    Symptoms of overdose include hypotension. Oral LD<sub>50</sub> is greater than 1000 mg/kg in mice and rats.

  • absorprion:

    65%

  • halflife:

    22 hours

  • roouteelimination:

    On average only 4.8% of the dose was excreted as unchanged drug in the feces and only a trace of the total radioactivity in the urine was attributed to unchanged drug.

  • volumedistribution:

  • clearance: